Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

20 trials with published results (8%)

Research Maturity

106 completed trials (41% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

8 terminated out of 260 trials

Success Rate

93.0%

+6.4% vs benchmark

Late-Stage Pipeline

8%

21 trials in Phase 3/4

Results Transparency

19%

20 of 106 completed with results

Key Signals

20 with results93% success

Data Visualizations

Phase Distribution

185Total
Not Applicable (116)
Early P 1 (5)
P 1 (13)
P 2 (30)
P 3 (8)
P 4 (13)

Trial Status

Completed106
Unknown64
Recruiting44
Active Not Recruiting15
Not Yet Recruiting14
Terminated8

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 106 completed trials

Clinical Trials (260)

Showing 20 of 20 trials
NCT07740109Not ApplicableNot Yet Recruiting

The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT04634643RecruitingPrimary

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

NCT07093346Not ApplicableRecruiting

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT07051863RecruitingPrimary

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

NCT06982378WithdrawnPrimary

GLP-1 RA on Liver OMICS in MASLD

NCT04302051Withdrawn

Assessment of Fatty Liver With Thermo-acoustic Device

NCT02193295Not ApplicableRecruiting

Reversal of Lipid-Induced Insulin Resistance

NCT07493967Enrolling By InvitationPrimary

Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease

NCT04248335Phase 4Completed

Effect of Obesity on Proton Pump Inhibitors

NCT05424003Phase 2RecruitingPrimary

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NCT05979389Phase 1RecruitingPrimary

Bicalutamide Therapy in Young Women With NAFLD and PCOS

NCT06588699Phase 2Recruiting

Digoxin In NASH (CODIN)

NCT05884723Not ApplicableRecruiting

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

NCT05370053Not ApplicableCompleted

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

NCT06697977Not ApplicableCompletedPrimary

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

NCT05842850Not ApplicableRecruitingPrimary

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

NCT06410924Phase 2CompletedPrimary

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NCT05500586Phase 1Completed

The Effects of Glucagon on Hepatic Metabolism

NCT06275906Not ApplicableCompletedPrimary

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

NCT05669677Completed

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Scroll to load more

Research Network

Activity Timeline